Francisco
Marin Ortuño
Profesores Titulares de Universidad Vinculados H.V.Arrixaca
Institut Català de la Salut
Barcelona, EspañaPublications in collaboration with researchers from Institut Català de la Salut (10)
2022
-
Association of renin-angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study
Clinical Kidney Journal, Vol. 15, Núm. 1, pp. 79-94
-
Long-Term Variation in Kidney Function and Its Impact After Acute Myocardial Infarction
American Journal of Cardiology, Vol. 163, pp. 20-24
2020
-
Impact of implementing a dyslipidemia management guideline on cholesterol control for secondary prevention of ischemic heart disease in primary care
International Journal of Environmental Research and Public Health, Vol. 17, Núm. 22, pp. 1-15
2017
-
Clinical Implications of Focal Intimal Disruption in Patients With Type B Intramural Hematoma
Journal of the American College of Cardiology, Vol. 69, Núm. 1, pp. 28-39
-
Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database
Pharmacoepidemiology and Drug Safety, Vol. 26, Núm. 1, pp. 97-107
-
The use of a binary composite endpoint and sample size requirement: Influence of endpoints overlap
American Journal of Epidemiology, Vol. 185, Núm. 9, pp. 832-841
2016
-
Drug Therapy for Rate and Rhythm Control in Nonvalvular Atrial Fibrillation: A Cross-sectional Study with Electronic Health Records in a Primary Care Cohort
Clinical Therapeutics, Vol. 38, Núm. 4, pp. 863-873
-
Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular Atrial fibrillation: Phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database
BMJ Open, Vol. 6, Núm. 1
2005
-
Validity of composite end points in clinical trials
British Medical Journal, Vol. 330, Núm. 7491, pp. 594-596
2002
-
La influencia de los métodos de presentación de los resultados en ensayos clínicos sobre la eficacia de una intervención y la intencón de prescribir fármacos para la prevención cardiovascular
Revista Espanola de Cardiologia, Vol. 55, Núm. 10, pp. 1042-1051